Sharemaestro company-news research for Eli Lilly and Company (LLY), showing current tone, evidence confidence, direct company coverage, sector and industry context, completed price response and the source headlines used on the page. Scores describe published news evidence. Confidence describes the amount, freshness, source breadth and direct company relevance of that evidence. Price context is shown separately.
NYSE
United States
Measured evidence
Company news sentiment
LLY news sentiment
Eli Lilly and Company
Company headlines from the last 30 days, weighted by freshness, relevance, publisher quality and the strength of the wording. Price is shown separately.
30-day score55Neutral is 50
Balanced news tone
50/100 evidence confidence
96% direct company focus
38 current stories across 16 publishers
Current company news
Balanced news tone
The score uses 38 current company stories from 16 publishers.
Observed headline tone57/100
→
Published 30-day score55/100
Latest source headline
Eli Lilly Stock Falls While Retatrutide Lawsuits Expand
finance.yahoo.com · 12 Aug 2026 17:24
Older, less relevant and less reliable stories count for less. Confidence is shown separately.
What supports the score
38 current stories are mapped specifically to LLY.
The score uses 16 publishers rather than depending on one outlet.
The current stories agree at 84/100.
What limits the score
No major limit stands out.
55/100
News scoreBalanced news tone
50/100
Confidencebuilding confidence
96%/100
Company news38 company stories
84/100
Story agreement16/100 difference
News history
Daily score and story count over 30 days
15 Jul30 Jul13 Aug
News scoreStory count50 baseline
Confidence
How reliable the score is
Confidence uses the amount of news, separate publishers, direct company relevance, freshness and agreement. A high or low score is not automatically reliable.
Amount of evidence37
1.849 after freshness weightingSource breadth100
16 independent publishersCompany relevance96
share tied directly to this companyFreshness58
recency-weighted evidenceAgreement84
how closely stories agreePublisher mix39
less reliance on one publisherPrice and news history
News score and weekly price over 26 weeks
News tone and price action are not far from neutral.
One scoring method across the chart.Stored company headlines are recalculated at each weekly point with the current 30-day freshness weighting. Old published snapshots are left unchanged.
13 Feb15 May07 Aug
Weekly close, indexedSentiment score
WeekNews scoreCloseWeekly move
07 Aug 202647USD 1185.71+3.2%
31 Jul 202652USD 1148.84-3.9%
24 Jul 202650USD 1196.03+1.4%
17 Jul 202650USD 1179.11-0.8%
10 Jul 202651USD 1188.58-2.1%
03 Jul 202650USD 1213.91+0.5%
26 Jun 202650USD 1208.12+10.0%
News subjects
What is shaping the score
Market update4717 stories · 45%
Regulatory and legal4911 stories · 29%
Earnings758 stories · 21%
Analyst action501 stories · 3%
Deals and strategy501 stories · 3%
Source mix
Where the evidence comes from
finance.yahoo.com5718 stories · 47%
Motley Fool503 stories · 8%
nasdaq.com632 stories · 5%
Simply Wall St.502 stories · 5%
GuruFocus.com502 stories · 5%
Zacks661 stories · 3%
seekingalpha.com501 stories · 3%
Recurring subjects
Subjects appearing most often
Earnings7EARNINGS7Pharma6PHARMA6Clinical Trials6CLINICAL-TRIALS6Fda Approval5FDA-APPROVAL5Obesity4OBESITY4
Earlier readings
How the score has changed
Past and present use the same method.Each point recalculates the previous 30 days of stored company headlines with today's scoring rules. The original stored snapshots remain unchanged.
20 Jun50 neutral13 Aug 22:39
ConstructiveBalanced or withheldCautious
Changes in the stored score
Scores are rebuilt from stored headlines with the current 30-day method. Days with no change are collapsed.
| Observed | Score | Move | Confidence | Stories | Status |
|---|---|---|---|---|---|
| 13 Aug 22:39 | 59 | +0 | 65/100 (+1) | 90 (+11) | Measured |
| 12 Aug 23:59 | 59 | -2 | 64/100 (+2) | 79 (+12) | Measured |
| 11 Aug 23:59 | 61 | +0 | 62/100 (+3) | 67 (+11) | Measured |
| 10 Aug 23:59 | 61 | +2 | 59/100 (+8) | 56 (+16) | Measured |
| 09 Aug 23:59 | 59 | +1 | 51/100 (-1) | 40 (+1) | Measured |
| 08 Aug 23:59 | 58 | +11 | 52/100 (+17) | 39 (+10) | Measured |
| 07 Aug 23:59 | 47 | -4 | 35/100 (+5) | 29 (0) | Provisional |
| 05 Aug 23:59 | 51 | +0 | 30/100 (-1) | 29 (-2) | Provisional |
Source headlines
The news behind the score
Only company-specific stories enter this score. The latest 30 days are shown newest first, with newer stories weighted more heavily and duplicate coverage combined.
#3150Tone
Barrons.comDirect company coverageScored from headlineSource lookup
Eli Lilly and Novo Nordisk Are Locked in a Legal War. Don’t Lose Sight of the Main Event.
- Published
- 24 Jul 2026 21:42
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 19.9d old
- Duplicates
- 10 consolidated
#3250Tone
Clinical Trials ArenaDirect company coverageScored from headlineSource lookup
Another win for Lilly’s triple-g agonist in two more Phase III trials
- Published
- 23 Jul 2026 15:07
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 21.2d old
- Duplicates
- 10 consolidated
#3350Tone
GuruFocusDirect company coverageScored from headlineSource lookup
Eli Lilly (LLY) Advances Next-Gen Weight-Loss Therapy with Promi
- Published
- 23 Jul 2026 12:31
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 21.3d old
- Duplicates
- 10 consolidated
#3450Tone
Pharmaceutical TechnologyDirect company coverageScored from headlineSource lookup
Novo sues Lilly after alleged misleading and false advertising campaign
- Published
- 21 Jul 2026 16:47
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 23.1d old
- Duplicates
- 10 consolidated
#3550Tone
Motley FoolDirect company coverageScored from headlineSource lookup
Now That Eli Lilly Trades Above $1,000, Is a Stock Split Finally on the Table?
- Published
- 20 Jul 2026 20:47
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 24.0d old
- Duplicates
- 10 consolidated
#3643Tone
Motley FoolDirect company coverageScored from headlineSource lookup
Watch Out, Eli Lilly and Novo Nordisk: Viking Therapeutics Just Started Testing a Weight Loss Drug That Goes Beyond GLP-1
- Published
- 18 Jul 2026 21:53
- News subject
- Market update
- Why this score
- Negative financial language
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 25.9d old
- Duplicates
- 10 consolidated
#3750Tone
Investor's Business DailyDirect company coverageScored from headlineSource lookup
Eli Lilly Trips Into Red-Hot Psychedelics Space With A Big Takeover
- Published
- 16 Jul 2026 21:21
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 28.0d old
- Duplicates
- 10 consolidated
#3850Tone
GuruFocus.comDirect company coverageScored from headlineSource lookup
Eli Lilly Buys AtaiBeckley for Up to $3.8 Billion
- Published
- 16 Jul 2026 19:11
- News subject
- Market update
- Why this score
- No clear positive or negative phrase
- Company focus
- Main company · 100%
- How it is used
- Direct company coverage
- Weighted influence
- Low · <0.1% · 28.0d old
- Duplicates
- 10 consolidated
Earlier company news
LLY news archive
Stored newest first for historical research. It starts after the newest three pages above and then continues through older news. Each archive page is loaded only when it is opened.
Older news is kept in the archive
There are 25 older LLY headlines. Open one page at a time when you need them.
Open older archiveProvider matches checked
Provider mentions not used in the score
A news provider linked these stories to LLY, but the headline and available text are not mainly about Eli Lilly and Company. They are kept here for transparency and do not affect the score, confidence, history or wider market totals.
Provider mentions are kept separate
Open the list to see which provider matches were checked and left out of LLY sentiment.
Open provider mentionsHow the page works
How to read the score
It describes the weighted balance of qualifying headlines. A score of 50 can mean balanced news or that there is not enough evidence; the status label explains which.
Confidence measures depth, source breadth, direct relevance, freshness and agreement. It does not rise merely because the tone is extreme.
Weekly price response, trend and fair-value position test whether the market is accepting or rejecting the news. They never rewrite the news score.
It measures news already published. It is not a forecast, recommendation or price target.